Literature DB >> 5497805

Destruction of chlorpromazine during absorption by rat intestine in vitro.

S H Curry, A D'Mello, G P Mould.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5497805      PMCID： PMC1703093     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  4 in total

1.  A preparation of surviving rat small intestine for the study of absorption.

Authors:  R B FISHER; D S PARSONS
Journal:  J Physiol       Date:  1949-12-15       Impact factor: 5.182

2.  Studies of delayed-action medication. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine.

Authors:  L E Hollister; S H Curry; J E Derr; S L Kanter
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

3.  Factors affecting chlorpromazine plasma levels in psychiatric patients.

Authors:  S H Curry; J M Davis; D S Janowsky; J H Marshall
Journal:  Arch Gen Psychiatry       Date:  1970-03

4.  The physiological disposition of chlorpromazine in the rat and dog.

Authors:  S H Curry; J E Derr; H M Maling
Journal:  Proc Soc Exp Biol Med       Date:  1970-05
  4 in total
  3 in total

Review 1.  Rectal drug administration: clinical pharmacokinetic considerations.

Authors:  A G de Boer; F Moolenaar; L G de Leede; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

2.  Clinical pharmacokinetic studies of perphenazine.

Authors:  C Eggert Hansen; T Rosted Christensen; J Elley; L Bolvig Hansen; P Kragh-Sorensen; N E Larsen; J Naestoft; E F Hvidberg
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

3.  Destruction of chlorpromazine during absorption in the rat in vivo and in vitro.

Authors:  S H Curry; A D'Mello; G P Mould
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.